Literature DB >> 21233218

Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages.

Chenggang Zhu1, Carlos Solorzano, Saurabh Sahar, Natalia Realini, Ernest Fung, Paolo Sassone-Corsi, Daniele Piomelli.   

Abstract

Palmitoylethanolamide (PEA) is an endogenous lipid amide that modulates pain and inflammation by engaging peroxisome proliferator-activated receptor type-α. Here, we show that the proinflammatory bacterial endotoxin lipopolysaccharide (LPS) decreases PEA biosynthesis in RAW264.7 macrophages by suppressing the transcription of N-acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD), which catalyzes the production of PEA and other lipid amides. Using a luciferase reporter construct and chromatin immunoprecipitation, we further show that LPS treatment reduces acetylation of histone proteins bound to the NAPE-PLD promoter, an effect that is blocked by the histone deacetylase inhibitor trichostatin A. The transcription factor Sp1 is involved in regulating baseline NAPE-PLD expression but not in the transcriptional suppression induced by LPS. The ability of LPS to down-regulate PEA biosynthesis is impaired in peritoneal macrophages from mutant NAPE-PLD-deficient mice, in which PEA is produced through a compensatory mechanism distinct from NAPE-PLD. Moreover, NAPE-PLD-deficient mice fail to mount a normal inflammatory reaction in response to carrageenan administration in vivo. Our findings suggest that proinflammatory stimuli suppress NAPE-PLD expression and PEA biosynthesis in macrophages and that this effect might contribute to the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21233218      PMCID: PMC3063731          DOI: 10.1124/mol.110.070201

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  38 in total

Review 1.  Points of control in inflammation.

Authors:  Carl Nathan
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

2.  Prophylactic efficacy of N-2-hydroxyethyl palmitamide (impulsin) in acute respiratory tract infections.

Authors:  K Masek; F Perlík; J Klíma; R Kahlich
Journal:  Eur J Clin Pharmacol       Date:  1974-10-04       Impact factor: 2.953

3.  Inhibitory effect of palmitoylethanolamide on gastrointestinal motility in mice.

Authors:  R Capasso; A A Izzo; F Fezza; A Pinto; F Capasso; N Mascolo; V Di Marzo
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

4.  Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

Authors:  M Yoshida; M Kijima; M Akita; T Beppu
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

5.  Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons.

Authors:  S Chatterjee; K Zaman; H Ryu; A Conforto; R R Ratan
Journal:  Ann Neurol       Date:  2001-03       Impact factor: 10.422

6.  Distinct regions of Sp1 modulate DNA binding and transcriptional activation.

Authors:  J T Kadonaga; A J Courey; J Ladika; R Tjian
Journal:  Science       Date:  1988-12-16       Impact factor: 47.728

7.  Effects of palmitoylethanolamide on signaling pathways implicated in the development of spinal cord injury.

Authors:  Tiziana Genovese; Emanuela Esposito; Emanuela Mazzon; Rosanna Di Paola; Rosaria Meli; Placido Bramanti; Daniele Piomelli; Antonio Calignano; Salvatore Cuzzocrea
Journal:  J Pharmacol Exp Ther       Date:  2008-03-26       Impact factor: 4.030

8.  Therapeutic effect of the endogenous fatty acid amide, palmitoylethanolamide, in rat acute inflammation: inhibition of nitric oxide and cyclo-oxygenase systems.

Authors:  Barbara Costa; Silvia Conti; Gabriella Giagnoni; Mariapia Colleoni
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

9.  Studies on prophylactic efficacy of N-2-hydroxyethyl palmitamide (Impulsin) in acute respiratory infections. Serologically controlled field trials.

Authors:  R Kahlich; J Klíma; F Cihla; V Franková; K Masek; M Rosický; F Matousek; J Bruthans
Journal:  J Hyg Epidemiol Microbiol Immunol       Date:  1979

10.  Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells.

Authors:  Jaejoon Won; Jeongbin Yim; Tae Kook Kim
Journal:  J Biol Chem       Date:  2002-07-31       Impact factor: 5.157

View more
  33 in total

Review 1.  Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain.

Authors:  Stephen D Skaper; Laura Facci; Mariella Fusco; Maria Federica Della Valle; Morena Zusso; Barbara Costa; Pietro Giusti
Journal:  Inflammopharmacology       Date:  2013-11-01       Impact factor: 4.473

Review 2.  Phospholipase D: enzymology, functionality, and chemical modulation.

Authors:  Paige E Selvy; Robert R Lavieri; Craig W Lindsley; H Alex Brown
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

Review 3.  A lipid gate for the peripheral control of pain.

Authors:  Daniele Piomelli; Andrea G Hohmann; Virginia Seybold; Bruce D Hammock
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 4.  Endocannabinoid signalling in innate and adaptive immunity.

Authors:  Valerio Chiurchiù; Luca Battistini; Mauro Maccarrone
Journal:  Immunology       Date:  2015-03       Impact factor: 7.397

5.  Endogenous N-acyl taurines regulate skin wound healing.

Authors:  Oscar Sasso; Silvia Pontis; Andrea Armirotti; Giorgia Cardinali; Daniela Kovacs; Marco Migliore; Maria Summa; Guillermo Moreno-Sanz; Mauro Picardo; Daniele Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2016-07-13       Impact factor: 11.205

6.  A role for oleoylethanolamide in chronic lymphocytic leukemia.

Authors:  M Masoodi; E Lee; M Eiden; A Bahlo; Y Shi; R B Ceddia; C Baccei; P Prasit; D E Spaner
Journal:  Leukemia       Date:  2014-01-13       Impact factor: 11.528

7.  Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.

Authors:  Lilu Guo; Zhongyi Chen; Venkataraman Amarnath; Patricia G Yancey; Brian J Van Lenten; Justin R Savage; Sergio Fazio; MacRae F Linton; Sean S Davies
Journal:  Antioxid Redox Signal       Date:  2015-03-18       Impact factor: 8.401

8.  Bile Acid Recognition by NAPE-PLD.

Authors:  Eleonora Margheritis; Beatrice Castellani; Paola Magotti; Sara Peruzzi; Elisa Romeo; Francesca Natali; Serena Mostarda; Antimo Gioiello; Daniele Piomelli; Gianpiero Garau
Journal:  ACS Chem Biol       Date:  2016-09-12       Impact factor: 5.100

9.  Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Authors:  Dario Siniscalco; Anna Sapone; Catia Giordano; Alessandra Cirillo; Laura de Magistris; Francesco Rossi; Alessio Fasano; James Jeffrey Bradstreet; Sabatino Maione; Nicola Antonucci
Journal:  J Autism Dev Disord       Date:  2013-11

10.  Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.

Authors:  Emma Leishman; Ken Mackie; Serge Luquet; Heather B Bradshaw
Journal:  Biochim Biophys Acta       Date:  2016-03-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.